Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) – Rafarma Pharmaceuticals, Inc. OTC: (RAFA) is an international biotechnology and pharmaceutical company that combines research centers and modern pharmaceutical production that meets international GMP standards. Rafarma Pharmaceuticals has consolidated and is in the process of consolidating a number of industrial companies, the …
Read More »Sermonix Pharmaceuticals Announces Breast Cancer Research
The article demonstrates the ability of lasofoxifene to inhibit primary tumor growth and reduce metastasis in mouse models, both as monotherapy and in combination with palbociclib Study results demonstrate the potential of lasofoxifene as a next-generation selective estrogen receptor modulator (SERM) with a clinical profile differentiated from other SERMs / …
Read More »Analysis of Hpq Silica Pharmaceutical Market Needs, Trends and Drivers – KSU
A Global Hpq Silica Pharmaceutical Market Report By PMR The Global Hpq Silica Pharmaceutical Market The report examines the behavior of the market and how the market behaved and reacted to various situations. Starting with some basic definitions associated with the Hpq Silica Pharmaceutical market, the report moves on to …
Read More »Algernon Pharmaceuticals Inc Receives Positive Feedback From U.S. Food and Drug Administration For Its DMT Stroke Program
The pharmaceutical company is researching AP-188 (N, N-Dimethyltryptamine or DMT), as part of a physiotherapy program for stroke rehabilitation. Algernon Pharmaceuticals Inc (CSE: AGN) (OTCQB: AGNPF) (FRA: AGW) said it has received positive feedback from the United States Food and Drug Administration (FDA) on its plans to investigate the use …
Read More »Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Barium X-ray Contrast
May 17, 2021 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC: VYYRF) (the “Company” or “Traveler”) is pleased to announce that it has received approval from Health Canada (HC) for its fifth product, MultiXthick Barium Sulfate Suspension containing 105% w / v barium sulfate suspension for oral and rectal administration …
Read More »Eloxx Pharmaceuticals Inc (ELOX) up 3.70% pre-market
Eloxx Pharmaceuticals Inc (Eloxx Pharmaceuticals Inc (ELOX) was up Monday morning, with the stock adding 3.70% pre-trade to 1.4. ELOX’s short-term technical score of 4 indicates that the stock has traded less bullish in the past month than 96% of the stocks in the market. In the biotech industry, which …
Read More »Marinus Pharmaceuticals (MRNS) Reports First Quarter Loss, Misses Revenue Estimates – May 17, 2021
Marinus Pharmaceuticals (Quick quote MRNSMRNS – Free Report) came out with a quarterly loss of $ 0.74 per share compared to Zacks’ consensus estimate of a loss of $ 0.46. This compares to a loss of $ 1.28 per share a year ago. These figures are adjusted for non-recurring items. …
Read More »Zynerba Pharmaceuticals announces podium and poster
DEVON, Pa., May 17, 2021 (GLOBE NEWSWIRE) – Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), a leader in innovative transdermal transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced an oral podium presentation and poster presentation at the Virtual ISPOR 2021 conference which will take place May 17-20, 2021. Podium …
Read More »Pharmaceutical company Boldon IDS set to be acquired for £ 110million
Pharmaceutical company South Tyneside Immunodiagnostic Systems is expected to be acquired by a US company in a deal worth £ 110million. The Boldon company, known as IDS, recommends that shareholders accept $ 155 million from US life science firm PerkinElmer. The company, which was founded in 1977, specializes in the …
Read More »Northeastern pharmaceutical company IDS to be acquired in £ 110million deal
A North East-based pharmaceutical company is expected to be acquired in a deal worth £ 110million. Boldon, South Tyneside-based Immunodiagnostic Systems (IDS) has entered into a $ 155 million buyout deal with US life science company PerkinElmer. IDS was founded in 1977 as RIA UK and specializes in the development, …
Read More »